Entelo Bio Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series 1
- Latest Deal Amount
-
$4M
- Investors
-
6
Entelo Bio General Information
Description
Operator of a biological research platform intended to analyse disease biology and support precision medicine research. The company's platform offers biological data analysis and disease insights, enabling researchers and healthcare organizations to identify disease mechanisms and support the development of targeted treatments.
Contact Information
Website
www.entelo.bioCorporate Office
- Bioescalator Innovation Building
- Old Road Campus Roosevelt Drive
- Oxford OX3 7FZ
- England, United Kingdom
Corporate Office
- Bioescalator Innovation Building
- Old Road Campus Roosevelt Drive
- Oxford OX3 7FZ
- England, United Kingdom
Entelo Bio Timeline
Entelo Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series 1) | 24-Apr-2026 | $4M | Completed | Startup | ||
| 3. Seed Round | 03-Dec-2024 | Completed | Startup | |||
| 2. Seed Round | 02-Jan-2023 | $1.2M | $1.2M | Completed | Startup | |
| 1. University Spin-Out | 14-Nov-2022 | Completed | Startup |
Entelo Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Entelo Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Entelo Bio Patents
Entelo Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4829035-A1 | Method | Pending | 22-Dec-2023 |
Entelo Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Entelo Bio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ananda Ventures (Germany) | Venture Capital | Minority | ||
| Mishcon de Reya | Corporation | Minority | ||
| Rockmount Seed Investments | Corporate Venture Capital | Minority | ||
| Creator Fund | Venture Capital | Minority | ||
| Hawktail | Venture Capital | Minority |
Entelo Bio FAQs
-
When was Entelo Bio founded?
Entelo Bio was founded in 2022.
-
Where is Entelo Bio headquartered?
Entelo Bio is headquartered in Oxford, United Kingdom.
-
What is the size of Entelo Bio?
Entelo Bio has 8 total employees.
-
What industry is Entelo Bio in?
Entelo Bio’s primary industry is Biotechnology.
-
Is Entelo Bio a private or public company?
Entelo Bio is a Private company.
-
What is Entelo Bio’s current revenue?
The current revenue for Entelo Bio is .
-
How much funding has Entelo Bio raised over time?
Entelo Bio has raised $7.99M.
-
Who are Entelo Bio’s investors?
Ananda Ventures (Germany), Mishcon de Reya, Rockmount Seed Investments, Creator Fund, and Hawktail are 5 of 6 investors who have invested in Entelo Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
